A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment
Anavex Life Sciences shares were up 7% to $11.25 after the company said it saw positive trial results for its oral blarcamesine for the treatment of early Alzheimer's disease. The clinical-stage ...
Anavex Life Sciences Announces Peer-Reviewed Publication of Oral Blarcamesine Phase IIb/III ...
Blarcamesine potential novel oral treatment to target upstream Alzheimer’s disease pathology through autophagy enhancementImpairment of autophagy ...
The Amazing Times on MSN6 小时
Five Common Medications That May Increase Your Risk of Dementia
Dementia, a progressive disorder that impacts memory and independence, affects millions globally. While many are aware of ...
Armed robbery in Revesby7 小时
Researchers Study Cannabis For Late-stage Dementia
Researchers at the University of Kentucky (UK) are part of a groundbreaking clinical trial exploring the use of medical ...
Medscape7 小时
Updated Alzheimer’s Guidelines Chart the Full Diagnostic Journey
Expanded clinical practice guidelines aim to empower all clinicians, regardless of specialty or practice setting to evaluate ...